EUCTR2014-003504-79-Outside-EU/EEA进行中（未招募）不适用
A Phase 3, Randomized, Observer-blind, Controlled, Multi-Center Study to Evaluate the Lot to Lot Consistencyof Investigational Meningococcal ACWY Conjugate Vaccine when One Dose is Administered to Healthy Adolescents 11-18 Years of Age and to Compare the Safety and Immunogenicity of Investigational Meningococcal ACWY Conjugate Vaccine with that of Licensed Meningococcal ACWY Conjugate Vaccine (Menactra™) when One Dose is Administered to Healthy Subjects 11-55 Years of Age
ovartis Vaccines & Diagnostics, Inc.0 个研究点目标入组 3,539 人开始时间: 2014年10月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 3,539
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Healthy subjects who are 11-55 years of age inclusive and who have given appropriate written assent and/or consent.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 1636
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 1332
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •Subjects with:
- •A previous or suspected disease caused by N. meningitidis
- •Previous immunization with a meningococcal vaccine or vaccine containing meningococcal antigen(s)
- •Previous or suspected disease caused by N. meningitidis
- •Any serious acute, chronic or progressive disease
- •Pregnant or breastfeeding
研究者
相似试验
进行中（未招募）
1 期
Clinical study in adults 50-64 years old to evaluate immunogenicity and safety of adjuvanted flu vaccine in comparison with a licensed non-adjuvanted flu vaccineProphylaxis of InfluenzaMedDRA version: 20.0Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsEUCTR2021-001721-40-DESeqirus UK Limited2,018
进行中（未招募）
不适用
Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of AgeEUCTR2014-003514-91-Outside-EU/EEAovartis Vaccines and Diagnostics S.r.l.1,500
进行中（未招募）
1 期
Clinical study in adults 50-64 years old to evaluate immunogenicity and safety of adjuvanted flu vaccine in comparison with a licensed non-adjuvanted flu vaccineEUCTR2021-001721-40-EESeqirus UK Limited2,018
进行中（未招募）
1 期
The Celljuvant study, A phase 3 Immunogenicity and Safety Study of aQIVc HD Vaccine in Adults aged 50 years and older.CTIS2023-503763-42-00Seqirus UK Limited6,300
进行中（未招募）
1 期
A Phase 3, Randomized, Controlled, Observer-Blind, Multi-Center Study Assessing the Immunogenicity and Safety of Single Dose of Novartis Meningococcal ACWY Conjugate Vaccine, administered to Healthy Toddlers 12 Months of Age, Compared to Single Dose of Meningococcal C Conjugate VaccineTo demonstrate non-inferiority of MenACWY vaccine to that of MenC vaccinegiven to healthy toddlers, as measured by the percentage of subjects with serumbactericidal assay using human complement (hSBA) titers =8 against N.meningitidis serogroup C, at 28 days after the vaccination.MedDRA version: 16.0Level: PTClassification code 10027202Term: Meningitis bacterialSystem Organ Class: 10021881 - Infections and infestationsEUCTR2013-000145-39-CZovartis Vaccines and Diagnostics s.r.l1,000